Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott glucose meter patent suit

This article was originally published in The Gray Sheet

Executive Summary

San Francisco federal jury rules Aug. 8 that Abbott patent '890 related to blood glucose monitors and test strips is invalid. Abbott had asserted in 2004 that Becton Dickinson and Nova Biomedical, which manufactured certain BD products including the BD Logic monitor, infringed four of its patents. The latest ruling relieves BD/Nova from the last of the four claims. A judge ruled in April that two of the other patents had not been infringed and one was invalid. Abbott had sought $42 million in damages. BD exited the glucose monitoring market in 2006 (1"The Gray Sheet" Oct. 2, 2006, p. 13)
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT026453

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel